Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.
Cannabis legislation is threatening to reduce pharmaceutical stock value by billions of dollars as more people are predicted to opt for weed over opioids.
Medical cannabis remains difficult to attain in healthcare under the British government, but it holds great promise for both NHS patients and the economy.
Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?
